Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabinoids for appetite and nutrition in palliative pancreatic cancer
2017-000530-54Phase 2Completed
- Sponsor
- University of Copenhagen
- Start
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dronabinol and cannabidiol in pancreatic cancer (PC) and protein-calorie malnutrition (PCM) (2 arms), sponsored by University of Copenhagen. Primary endpoint: Intake of protein and energy. Started Mar 2017; status: completed.
02
Drugs
dronabinolcannabidiol
03
Conditions
pancreatic cancer (PC)protein-calorie malnutrition (PCM)
Beyond the preview
Go deeper on 2017-000530-54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-000530-54.